(Q36589413)

15 August 2017

1 reference

title

Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis (English)

1 reference

15 August 2017

1 reference

Hanauer SB

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Alimentary Pharmacology & Therapeutics

15 August 2017

published in

1 reference

15 August 2017

volume

24 Suppl 3

1 reference

15 August 2017

page(s)

37-40

1 reference

Biologic therapy of inflammatory bowel disease.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

Review article: monitoring for drug side-effects in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

Rational selection of oral 5-aminosalicylate formulations and prodrugs for the treatment of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.03058.X

10.1111/J.1365-2036.2006.03058.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference